Difference between revisions of "PCC TC Face to Face July 22 26, 2019 Minutes"
Jump to navigation
Jump to search
Line 38: | Line 38: | ||
** DCP public comments | ** DCP public comments | ||
***C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-40: Persuasive | ***C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-40: Persuasive | ||
− | ***C-09, C-13, C-14, C-18: Emma needs input from Jeff | + | ***C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff |
***C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D | ***C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D | ||
***C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions | ***C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions |
Revision as of 07:36, 23 July 2019
Monday July 22, 2019
- Attendees
- In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- Review Anti-trust and Patent Policy
- Format codes
- Format codes IHE and HL7 have their own format codes
- There is a lot of confusion for a vendor perspective between format codes and template ID
- Shall PCC work on a profile to manage this ?
- Agenda update see PCC_TC_Face_to_Face_July_22-26,_2019
- DCP and CDA-DSS (review of public comments)
- IPS-International Patient Summary (Profil proposal)
- Website [3]
- Attendees: same +
- In Person: Lori Fourquet, Derek,
- Via Webex: Michael Nusbaum
Tuesday July 23, 2019
- Attendees
- In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- DCP and CDA-DSS (review of public comments)
- DCP public comments
- C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-40: Persuasive
- C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff
- C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
- C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions
- DCP public comments
- CDA-DSS public comments
- CP session